In Vitro Diagnostics (IVD) Quality Control Market Analysis and Forecast to 2031: By Product & Service (Quality Controls, Data Management Solutions, Quality Assurance Services), Technology (Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation/Hemostasis, Others), Manufacturer Type (Third-party Controls, Original Equipment Manufacturer Controls), End Users (Hospitals, Clinical Laboratories, Academic & Research Institutes, Others), and Region

The global in vitro diagnostics quality control market was valued at USD 1.5 billion in 2021 and it is anticipated to grow further up to USD 2.2 billion by 2031, at a CAGR of 3.7% during the forecast period.

The effectiveness of in vitro diagnostic tests, including those for pathogen identification using in vitro nucleic acid testing, healthcare-associated illnesses (HAIs) such as pneumonia, urinary tract infections, and others, is assessed using IVD quality controls. These products primarily concentrate on defect detection, quality control, and validation panels like the Blood Culture (BCID) Control Panel, Human Papillomavirus (HPV) Control Panel, and others to support in the implementation and monitoring of the performance of clinical and research laboratories, blood diagnostic centers, and IVD manufacturers.

Global In Vitro Diagnostics Quality Control Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$ 1.5 Bn
Market Size in 2031$ 2.2 Bn
Growth Rate (2021-31)3.7%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct & Service, Technology, Manufacturer Type, End Users, Region
Key CompaniesBio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), and Helena Laboratories Corporation (US) among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

As the burden of various diseases increases globally, so has the number of laboratory tests. The number of laboratories in both the public and private sectors has increased in response to this need. With the start of the COVID-19 pandemic in December 2019, the demand for diagnostic tests has skyrocketed. Many government organizations have established new laboratories in response to this epidemic and to increase laboratory testing capacity. The majority of nations need clinical laboratories to get regulatory body accreditation before performing diagnostic tests. Additionally, accreditation to ISO 15189:2012 and other comparable standards is turning into a requirement in many nations. Authorities assess a laboratory’s competency and quality system during the accreditation process using predetermined standards. While some European nations, including Belgium, France, Hungary, Ireland, and Lithuania, require accreditation for a variety of laboratory tests, others, like Finland, the Netherlands, Sweden, Switzerland, and the UK, have practically finished the process.

Market Restraints and Challenges

It costs a lot of money to set up a QC process in a clinical laboratory. Additionally, laboratories must keep a specialized staff on hand to oversee the QC system. Moreover, regardless of the number of tests conducted, QC procedures are expensive. As a result, QC methods are particularly expensive to adopt for clinical laboratories that perform few diagnostic tests. This is predicted to lead to a lesser adoption of QC procedures, along with budgetary restrictions in many hospitals and laboratories in developed and emerging nations.

Global In Vitro Diagnostics Quality Control Market Segmental Overview

The report analyses the global in vitro diagnostics quality control market based on product & service, technology, manufacturer type, end user, and region.

Global In Vitro Diagnostics Quality Control Market by Products & Services

Based on products & services, it is segmented into quality control products, data management solutions, and quality assurance services. The quality control products segment is anticipated to dominate the market during the forecast period. The growth of the segments is primarily attributed to the upsurge in demand for quality controls to validate the accuracy, precision, and reliability of IVD test results.

Global In vitro Diagnostics Quality Control Market by Technology

Based on the technology, it is segmented into immunochemistry, clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation/hemostasis, and other technologies. The immunochemistry segment is anticipated to dominate the market during the forecast period. The increase in geriatric population, the number of accredited clinical laboratories, the adoption of third-party quality controls and POC instruments in developed regions, as well as the rising demand for external quality assessment programs, are the main factors driving the growth of the IVD quality control market.

Global In Vitro Diagnostics Quality Control Market by Manufacturer Type

Based on the manufacturer type, it is segmented into third party controls, and original equipment manufacturer control. The third-party controls segment is anticipated to dominate the market during the forecast period. The key factors such as the rising need for faster and error-free laboratory results coupled with improving laboratory efficiency, and technological advancements in multi-analyte third-party IVD quality controls are the major factors that significantly impacted the development in the market.

Global In Vitro Diagnostic Quality Control Market by End User

Based on the end user, it is segmented into hospitals, clinical laboratories, academic & research institutes, and other end users. The hospitals end user segment dominated the market during the forecast period. The increasing demand for multi-analyte and third-party controls is boosting the growth of the market.

Geographical Analysis of the In Vitro Diagnostic Quality Control Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the market during the forecast period. Owing to the increase in demand for technologically advanced multi-analyte controls and stringent mandates for using controls is propelling the growth of the market.

Major Players in the Global In Vitro Diagnostic Quality Control Market

The key players studied in the global in vitro diagnostic quality control market are Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), and Helena Laboratories Corporation (US) among others.

COVID-19 Impact

The COVID-19 pandemic has had an overall beneficial and negative influence on the IVD sector. The preceding year saw a significant decrease in the demand for diagnostic tests that are not available over-the-counter (OTC) and can only be performed with a doctor’s supervision (2019). However, there is a large demand for quick diagnostic tests, POC testing, and IVD devices used in drug discovery. To detect COVID-19, a number of business participants are concentrating on developing quick antigen testing. In order to fight the pandemic, regulatory agencies have also offered their assistance for the approval of these tests. As a result, both good and negative repercussions have been felt by the IVD business, and major players have made strategic moves to deal with the situation. To assure the accuracy and precision of patient sample results, the growing use of fast diagnostic tests, POC testing, and IVD devices further increases the demand for control and calibrator kits.

In order to maintain their market share and financial viability throughout the epidemic, several businesses altered their business models. For instance, the pharmaceutical business of F. Hoffmann-La Roche fell by 4% in 2020 compared to 2019. In order to launch COVID-19 rapid diagnostic tests coupled with controls and calibrators, the firm concentrated on investing in R&D, which boosted its revenue growth. The quality of test findings is a focus for businesses and laboratories, which has contributed to the market’s growth.

Recent Developments
  • August 2021, Zeptometrix Corporation announced the immediate availability of its ready to use NAT SARS-ERC for laboratory QC and test validation.
  • July 2021, Quidel Corporation received the CE Marke for its innovative Savanna multiplex molecular analyzers and Savanaa RVP4 Assay.
  • June 2021, LGS Sera Care expanded its line of SARS-CoV-2 molecular quality solutions to include AccuPlex SARS-CoV-2 variant panel 1.
  • June 2021, Abbott Laboratories received CE mark for its Panbio Rapid Antigen self-test. It helped the company expand its reach throughput Europe for fast, reliable COVID-19 testing.
Frequently Asked Questions

Q1. How big is the In Vitro Diagnostics Quality Control market?

Ans. The global In Vitro Diagnostics Quality Control market size was USD 1.5 billion in 2021 and is anticipated to reach USD 2.2 billion in 2031, growing at a rate of 3.7% from 2022 to 2031.

Q2. What is the In Vitro Diagnostics Quality Control market growth rate?

Ans. The growth rate of the In Vitro Diagnostics Quality Control market is 3.7%.

Q3. Which region holds a major market share for the In Vitro Diagnostics Quality Control market?

Ans. North America holds a major market share of the In Vitro Diagnostics Quality Control market in 2021.

Q4. Which segment accounted for the largest In Vitro Diagnostics Quality Control market share?

Ans. By end user, hospitals segment accounted for the largest In Vitro Diagnostics Quality Control market share.

Q5. Who are the key players in the In Vitro Diagnostics Quality Control market?

Ans. The global In Vitro Diagnostics Quality Control market report includes players such as Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), and Helena Laboratories Corporation (US) among others.

Q6. What are the factors driving the In Vitro Diagnostics Quality Control market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of In Vitro Diagnostics Quality Control market players?

Ans. The key growth strategies of In Vitro Diagnostics Quality Control market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the In Vitro Diagnostics Quality Control market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the In Vitro Diagnostics Quality Control market during the forecast period.

Table Of Contents

Chapter 1. Market Introduction
1.1. Objectives Of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of The Market

Chapter 3. In Vitro Diagnostics Quality Control Market Outlook
3.1. In Vitro Diagnostics Quality Control Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat Of New Entrants
3.3.2. Threat Of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. Pestle Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers And/or Retailers
3.6. Impact Of the Russia and Ukraine War on The Global In Vitro Diagnostics Quality Control Market

Chapter 4. The Economic Impact of Covid-19
4.1. Overall Impact of Covid-19
4.2. Impact Of Covid on The Global In Vitro Diagnostics Quality Control Market
4.3. Economic Impact Analysis

Chapter 5. In Vitro Diagnostics Quality Control Market by Product & Services
5.1. Market Overview
5.2. Quality Control Products
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
5.3. Data Management Solutions
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
5.4. Quality Assurance Services
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)

Chapter 6. In Vitro Diagnostics Quality Control Market by Technology
6.1. Market Overview
6.2. Immunochemistry
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.3. Clinical Chemistry
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.4. Molecular Diagnostics
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.5. Microbiology
6.5.1. Market Size and Forecast, 2021-2031 ($Million)
6.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.6. Hematology
6.6.1. Market Size and Forecast, 2021-2031 ($Million)
6.6.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.7. Coagulation/Hemostasis
6.7.1. Market Size and Forecast, 2021-2031 ($Million)
6.7.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.8. Others
6.8.1. Market Size and Forecast, 2021-2031 ($Million)
6.8.2. Market Size and Forecast, By Region, 2021-2031 ($Million)

Chapter 7. In Vitro Diagnostics Quality Control Market by Manufacturer Type
7.1. Market Overview
7.2. Third Party Controls
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
7.3. Original Equipment Manufacturer Controls
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)

Chapter 8. In Vitro Diagnostics Quality Control Market by End User
8.1. Market Overview
8.2. Hospitals
8.2.1. Market Size and Forecast, 2021-2031 ($Million)
8.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
8.3. Clinical Laboratories
8.3.1. Market Size and Forecast, 2021-2031 ($Million)
8.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
8.4. Academic & Research Institutes
8.4.1. Market Size and Forecast, 2021-2031 ($Million)
8.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
8.5. Others
8.5.1. Market Size and Forecast, 2021-2031 ($Million)
8.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)

Chapter 9. Global In Vitro Diagnostics Quality Control Market, By Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.2.3. North America In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.2.4. North America In Vitro Diagnostics Quality Control Market Size and Forecast by Country, 2021-2031, ($Million)
9.2.5. The U.S.
9.2.5.1. The U.S. In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.2.5.2. The U.S. In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.2.6. Canada
9.2.6.1. Canada In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.2.6.2. Canada In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.2.7. Mexico
9.2.7.1. Mexico In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.2.7.2. Mexico In Vitro Diagnostics Quality Control Market Size and Forecast by End User Technology, 2021-2031, ($Million)
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.3. Europe In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.3.4. Europe In Vitro Diagnostics Quality Control Market Size and Forecast by Country, 2021-2031, ($Million)
9.3.5. Germany
9.3.5.1. Germany In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.5.2. Germany In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.3.6. France
9.3.6.1. France In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.6.2. France In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.3.7. U.K.
9.3.7.1. U.K. In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.7.2. U.K. In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.3.8. Spain
9.3.8.1. Spain In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.8.2. Spain In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.3.9. Italy
9.3.9.1. Italy In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.9.2. Italy In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.3.10. Russia
9.3.10.1. Russia In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.10.2. Russia In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.3.11. Rest Of Europe
9.3.11.1. Rest Of Europe In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.3.11.2. Rest Of Europe In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific In Vitro Diagnostics Quality Control Market Size and Forecast by Country, 2021-2031, ($Million)
9.4.3. Asia-Pacific In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.4.4. Asia-Pacific In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.4.5. China
9.4.5.1. China In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.4.5.2. China In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.4.6. India
9.4.6.1. India In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.4.6.2. India In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.4.7. Japan
9.4.7.1. Japan In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.4.7.2. Japan In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.4.8. South Korea
9.4.8.1. South Korea In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.4.8.2. South Korea In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.4.9. Rest Of APAC
9.4.9.1. Rest Of APAC In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.4.9.2. Rest Of APAC In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.5. Rest Of the World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest Of the World In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.5.3. Rest Of the World In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.5.4. Rest Of the World In Vitro Diagnostics Quality Control Market Size and Forecast by Country, 2021-2031, ($Million)
9.5.5. Latin America
9.5.5.1. Latin America In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.5.5.2. Latin America In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.5.6. Middle East
9.5.6.1. Middle East In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.5.6.2. Middle East In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)
9.5.7. Africa
9.5.7.1. Africa In Vitro Diagnostics Quality Control Market Size and Forecast by Technology, 2021-2031, ($Million)
9.5.7.2. Africa In Vitro Diagnostics Quality Control Market Size and Forecast by End User, 2021-2031, ($Million)

Chapter 10. Competitive Landscape
10.1. Market Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Developmental Strategy Benchmarking
10.3.1. New End User Development
10.3.2. Technology Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Joint Ventures, And Collaborations
10.3.5. Mergers And Acquisitions

Chapter 11. Company Profiles
11.1. Bio-Rad Laboratories, Inc.
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Technology Offerings
11.1.4. Key Strategic Initiatives
11.1.5. SWOT Analysis
11.2. Randox Laboratories Ltd.
11.2.1. Company Snapshot
11.2.2. Financial Performance
11.2.3. Technology Offerings
11.2.4. Key Strategic Initiatives
11.2.5. SWOT Analysis
11.3. Thermo Fisher Scientific, Inc.
11.3.1. Company Snapshot
11.3.2. Financial Performance
11.3.3. Technology Offerings
11.3.4. Key Strategic Initiatives
11.3.5. SWOT Analysis
11.4. LGC Limited
11.4.1. Company Snapshot
11.4.2. Financial Performance
11.4.3. Technology Offerings
11.4.4. Key Strategic Initiatives
11.4.5. SWOT Analysis
11.5. Ortho Clinical Diagnostics
11.5.1. Company Snapshot
11.5.2. Financial Performance
11.5.3. Technology Offerings
11.5.4. Key Strategic Initiatives
11.5.5. SWOT Analysis
11.6. Abbott Laboratories
11.6.1. Company Snapshot
11.6.2. Financial Performance
11.6.3. Technology Offerings
11.6.4. Key Strategic Initiatives
11.6.5. SWOT Analysis
11.7. Roche Diagnostics
11.7.1. Company Snapshot
11.7.2. Financial Performance
11.7.3. Technology Offerings
11.7.4. Key Strategic Initiatives
11.7.5. SWOT Analysis
11.8. Siemens Healthineers
11.8.1. Company Snapshot
11.8.2. Financial Performance
11.8.3. Technology Offerings
11.8.4. Key Strategic Initiatives
11.8.5. SWOT Analysis
11.9. Danaher Corporation
11.9.1. Company Snapshot
11.9.2. Financial Performance
11.9.3. Technology Offerings
11.9.4. Key Strategic Initiatives
11.9.5. SWOT Analysis
11.10. Fortress Diagnostics
11.10.1. Company Snapshot
11.10.2. Financial Performance
11.10.3. Technology Offerings
11.10.4. Key Strategic Initiatives
11.10.5. SWOT Analysis
11.11. SERO AS
11.11.1. Company Snapshot
11.11.2. Financial Performance
11.11.3. Technology Offerings
11.11.4. Key Strategic Initiatives
11.11.5. SWOT Analysis
11.12. Sysmex Corporation
11.12.1. Company Snapshot
11.12.2. Financial Performance
11.12.3. Technology Offerings
11.12.4. Key Strategic Initiatives
11.12.5. SWOT Analysis
11.13. Ortho-Clinical Diagnostics
11.13.1. Company Snapshot
11.13.2. Financial Performance
11.13.3. Technology Offerings
11.13.4. Key Strategic Initiatives
11.13.5. SWOT Analysis
11.14. Helena Laboratories Corporation
11.14.1. Company Snapshot
11.14.2. Financial Performance
11.14.3. Technology Offerings
11.14.4. Key Strategic Initiatives
11.14.5. SWOT Analysis
*The List of Company Is Subject to Change During the Final Compilation of The Report

Global In Vitro Diagnostics Quality Control Market Segmentation

By Product & Service

  • Quality Control Products
  • Data Management Solutions
  • Quality Assurance Services

By Technology

  • Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation/Hemostasis
  • Others

By Manufacturer Type

  • Third Party Controls
  • Original Equipment Manufacturer Controls

By End User

  • Hospitals
  • Clinical Laboratories
  • Academic & Research Institutes
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • The Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Gynecomastia is a condition characterized by the enlargement…
Atrial fibrillation (AF) is a type of arrhythmia…
The global biliary stents market was valued at…
An automotive pneumatic actuator is a type of…
Personal Care and Cosmetics Microalgae are microorganisms that…
Medical affairs outsourcing refers to the practice of…
Laboratory automation is the process of automating various…
An insulin pen is an infusion device used…
Disposable gloves are gloves that are made to…
Healthcare technology management (HTM) is a field of…